How our benchmarking analysis contributed to a Hemato-Oncology company's sales and pricing strategy for specific agents.
The Challenge: Competitive benchmarking, including sales force and market…
How a hematology brand utilized competitor sales force research to defend itself against a competitor entrant in Spain.
The Challenge: How to react to a new entrant threat A hematology brand team of…
How a pharma in the multiple myeloma space gained access to leading KOLs insights and used them in its asset development process.
The Challenge: Understanding how KOLs define the treatment evolution and the…
How a large pharma in Hematology and Oncology space established and used competitive benchmarks across the US
The Challenge: Knowing field force performance against the competition A large…
Multiple myeloma treatment: Why we still need novel scientific research.
Multiple myeloma (MM) is an incurable form of hematological cancer affecting…
